Integration of red cell genotyping into the blood supply chain: A population-based study

The Lancet Haematology

Volumn 2, Issue 7, 2015, Pages e282-e288

  Flegel, Willy A ^a   Gottschall, Jerome L ^b,c   Denomme, Gregory A ^c  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD GROUP ANTIGEN;

ARTICLE; BLOOD DONOR; BLOOD TRANSFUSION; GENOTYPE; HUMAN; MICROARRAY ANALYSIS; NANOFLUIDICS; PHENOTYPE; PHENOTYPE MATCHING; PRIORITY JOURNAL; RED CELL GENOTYPE; SEROLOGY; SINGLE NUCLEOTIDE POLYMORPHISM; VASCULARIZATION; BLOOD BANK; BLOOD GROUP TYPING; CLASSIFICATION; ERYTHROCYTE; GENETICS; GENOTYPING TECHNIQUE; ORGANIZATION AND MANAGEMENT; WISCONSIN;

BLOOD BANKS; BLOOD DONORS; BLOOD GROUP ANTIGENS; BLOOD GROUPING AND CROSSMATCHING; ERYTHROCYTES; GENOTYPE; GENOTYPING TECHNIQUES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; WISCONSIN;

EID: 84944566314     PISSN: None     EISSN: 23523026     Source Type: Journal    
DOI: 10.1016/S2352-3026(15)00090-3     Document Type: Article

References (40)

1. Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988; 148: 2485-89.
2. Azarkeivan A, Ansari S, Ahmadi MH, et al. Blood transfusion and alloimmunization in patients with thalassemia: multicenter study. Pediatr Hematol Oncol 2011; 28: 479-85.
3. Sanz C, Nomdedeu M, Belkaid M, Martinez I, Nomdedeu B, Pereira A. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013; 53: 710-15.
4. Chou ST, Jackson T, Vege S, Smith-Whitley K, Friedman DF, WesthoffCM. High prevalence of red blood cell alloimmunization in sickle cell disease despite transfusion from Rh-matched minority donors. Blood 2013; 122: 1062-71.
5. Perseghin P, Balduzzi A, Galimberti S, et al. Red blood cell support and alloimmunization rate against erythrocyte antigens in patients undergoing hematopoietic stem cell transplantation. Bone Marrow Transplant 2003; 32: 231-36.
6. Franchini M, Gandini G, Aprili G. Non-ABO red blood cell alloantibodies following allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant 2004; 33: 1169-72.
7. Gajewski JL, Johnson VV, Sandler SG, Sayegh A, Klumpp TR. A review of transfusion practice before, during, and after hematopoietic progenitor cell transplantation. Blood 2008; 112: 3036-47.
8. Diedrich B, Andersson J, Sallander S, Shanwell A. K, Fy(a), and Jk(a) phenotyping of donor RBCs on microplates. Transfusion 2001; 41: 1263-67.
9. Le N, Harach ME, Kay JK, Brown RP, Everetts JN, Herman JH. Establishing an antigen-negative red blood cell inventory in a hospital-based blood bank. Transfusion 2014; 54: 285-88.
10. Denomme GA, Flegel WA. Applying molecular immunohematology discoveries to standards of practice in blood banks: now is the time. Transfusion 2008; 48: 2461-75.
11. Denomme GA. Molecular basis of blood group expression. Transfus Apher Sci 2011; 44: 53-63.
12. Patnaik SK, Helmberg W, Blumenfeld OO. BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems. Nucleic Acids Res 2012; 40 (database issue): D1023-29.
13. Wagner FF. Molecular testing in transfusion medicine. Expert Opin Med Diagn 2010; 4: 411-28.
14. Zimring JC, Welniak L, Semple JW, Ness PM, Slichter SJ, Spitalnik SL. Current problems and future directions of transfusion-induced alloimmunization: summary of an NHLBI working group. Transfusion 2011; 51: 435-41.
15. Avent ND. Large-scale blood group genotyping: clinical implications. Br J Haematol 2009; 144: 3-13.
16. Denomme GA. Prospects for the provision of genotyped blood for transfusion. Br J Haematol 2013; 163: 3-9.
17. Flegel WA, von Zabern I, Wagner FF. Six years' experience performing RHD genotyping to confirm D-red blood cell units in Germany for preventing anti-D immunizations. Transfusion 2009; 49: 465-71.
18. Klapper E, Zhang Y, Figueroa P, et al. Toward extended phenotype matching: a new operational paradigm for the transfusion service. Transfusion 2010; 50: 536-46.
19. ShafiH, Abumuhor I, Klapper E. How we incorporate molecular typing of donors and patients into our hospital transfusion service. Transfusion 2014; 54: 1212-19.
20. Wagner FF, Bittner R, Petershofen EK, Doescher A, Muller TH. Cost-efficient sequence-specific priming-polymerase chain reaction screening for blood donors with rare phenotypes. Transfusion 2008; 48: 1169-73.
21. St-Louis M, Perreault J, Lavoie J, et al. Genotyping of 21, 000 blood donors in Quebec and RHD analysis. Transfus Clin Biol 2010; 17: 242-48 (in French).
22. Meyer S, Vollmert C, Trost N, et al. High-throughput Kell, Kidd, and Duffy matrix-assisted laser desorption/ionization, time-of-flight mass spectrometry-based blood group genotyping of 4000 donors shows close to full concordance with serotyping and detects new alleles. Transfusion 2014; 54: 3198-207.
23. Hopp K, Weber K, Bellissimo D, Johnson ST, Pietz B. High-throughput red blood cell antigen genotyping using a nanofluidic real-time polymerase chain reaction platform. Transfusion 2010; 50: 40-46.
24. Flegel WA, Gottschall JL, Denomme GA. Implementing mass-scale red cell genotyping at a blood center. Transfusion (in press).
25. Daniels GL, Faas BH, Green CA, et al. The VS and V blood group polymorphisms in Africans: a serologic and molecular analysis. Transfusion 1998; 38: 951-58.
26. Faas BH, Beckers EA, Wildoer P, et al. Molecular background of VS and weak C expression in blacks. Transfusion 1997; 37: 38-44.
27. Irshaid NM, Henry SM, Olsson ML. Genomic characterization of the kidd blood group gene:different molecular basis of the Jk(a-b-) phenotype in Polynesians and Finns. Transfusion 2000; 40: 69-74.
28. Noizat-Pirenne F, Mouro I, Le Pennec PY, et al. Two new alleles of the RHCE gene in Black individuals: the RHce allele ceMO and the RHcE allele cEMI. Br J Haematol 2001; 113: 672-79.
29. Noizat-Pirenne F, Lee K, Pennec PY, et al. Rare RHCE phenotypes in black individuals of Afro-Caribbean origin: identification and transfusion safety. Blood 2002; 100: 4223-31.
30. Storry JR, Reid ME, Fetics S, Huang CH. Mutations in GYPB exon 5 drive the S-s-U+(var) phenotype in persons of African descent: implications for transfusion. Transfusion 2003; 43: 1738-47.
31. Tournamille C, Colin Y, Cartron JP, Le Van KC. Disruption of a GATA motif in the Duffy gene promoter abolishes erythroid gene expression in Duffy-negative individuals. Nat Genet 1995; 10: 224-28.
32. Tournamille C, Le Van KC, Gane P, et al. Arg89Cys substitution results in very low membrane expression of the Duffy antigen/receptor for chemokines in Fy(x) individuals. Blood 1998; 92: 2147-56.
33. Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008; 48: 2069-76.
34. Flickinger C, Petrone T, Church A. Review: American rare donor program. Immunohematology 2004; 20: 239-43.
35. Harm SK, Yazer MH, Monis GF, Triulzi DJ, Aubuchon JP, Delaney M. A centralized recipient database enhances the serologic safety of RBC transfusions for patients with sickle cell disease. Am J Clin Pathol 2014; 141: 256-61.
36. Seltsam A, Wagner FF, Salama A, Flegel WA. Antibodies to highfrequency antigens may decrease the quality of transfusion support: an observational study. Transfusion 2003; 43: 1563-66.
37. Storry JR, Jöud M, Christophersen MK, et al. Homozygosity for a null allele of SMIM1 defines the Vel-negative blood group phenotype. Nat Genet 2013; 45: 537-41.
38. Cvejic A, Haer-Wigman L, Stephens JC, et al. SMIM1 underlies the Vel blood group and influences red blood cell traits. Nat Genet 2013; 45: 542-45.
39. Ballif BA, Helias V, Peyrard T, et al. Disruption of SMIM1 causes the Vel-blood type. EMBO Mol Med 2013; 5: 751-61.
40. Kacker S, Vassallo R, Keller MA, et al. Financial implications of RHD genotyping of pregnant women with a serologic weak D phenotype. Transfusion 2015; published online March 21. DOI:10.1111/trf.13074.